Rapid and Effective Elimination of Myoglobin with CytoSorb® Hemoadsorber in Patients with Severe Rhabdomyolysis

被引:8
|
作者
Albrecht, Frederic [1 ,2 ]
Schunk, Stefan [2 ,3 ]
Fuchs, Maren [1 ,2 ]
Volk, Thomas [1 ,2 ]
Geisel, Juergen [2 ,4 ]
Fliser, Danilo [2 ,3 ]
Meiser, Andreas [1 ,2 ]
机构
[1] Saarland Univ, Med Ctr, Dept Anesthesiol Intens Care & Pain Therapy, Homburg, Germany
[2] Saarland Univ, Fac Med, Homburg, Germany
[3] Saarland Univ, Med Ctr, Dept Internal Med Nephrol & Hypertens 4, Homburg, Germany
[4] Saarland Univ, Med Ctr, Dept Clin Chem & Lab Med, Homburg, Germany
关键词
Acute kidney injury; Continuous renal replacement therapy; Hemoadsorber; Myoglobin; Renal replacement therapy; Rhabdomyolysis; HEMODIAFILTRATION; REMOVAL;
D O I
10.1159/000534479
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Rhabdomyolysis is characterized by destruction of muscle fibers by various causes and is diagnosed by increased creatine kinase concentrations in the blood. Myoglobin released into the blood may cause acute kidney injury. In this randomized controlled study, we hypothesized that myoglobin elimination would be faster when a hemoadsorber was added to a continuous veno-venous hemodialysis (CVVHD). Methods: Four patients in the control group received CVVHD with a high cut-off hemofilter using high blood and dialysate flows for 48 h. Four patients in the CytoSorb group received the same treatment, but in addition, the hemoadsorber CytoSorb (R) was inserted in front of the hemofilter and replaced once after 24 h. Blood samples were drawn simultaneously before (pre) and after (post) the hemofilter or else the hemoadsorber, after 5 and 30 min, as well as after 2, 4, 8, and 24 h. All measurements were repeated the next day after the hemoadsorber had been renewed in the CytoSorb group. Primary outcome was the area under the curve (AUC) of the relative myoglobin concentrations as percent of baseline. To evaluate the efficacy of myoglobin removal, relative reductions in myoglobin concentrations during one passage through each device at each time point were calculated. Results: Patients in the CytoSorb group had a significantly lower AUC during the first 24 h (42 +/- 10% vs. 63 +/- 6%, p = 0.029) as well as during the observation period of 48 h (26 +/- 7% vs. 51 +/- 12%, p = 0.029). The relative reductions for myoglobin were considerably higher in the CytoSorb group compared to the control group during the first 8 h. Conclusion: Myoglobin concentrations declined considerably faster when CytoSorb was added to a CVVHD. When compared to a high-cut-off hemofilter, efficacy of CytoSorb in myoglobin elimination was much better. Because of saturation after 8-12 h an exchange may be necessary.(c) 2023 The Author(s).Published by S. Karger AG, Basel
引用
收藏
页码:88 / 95
页数:8
相关论文
共 45 条
  • [1] Myoglobin adsorption and saturation kinetics of the cytokine adsorber Cytosorb® in patients with severe rhabdomyolysis: a prospective trial
    Graf, Helen
    Graefe, Caroline
    Bruegel, Mathias
    Zoller, Michael
    Maciuga, Nils
    Frank, Sandra
    Weidhase, Lorenz
    Paal, Michael
    Scharf, Christina
    ANNALS OF INTENSIVE CARE, 2024, 14 (01):
  • [2] Severe rhabdomyolysis after exertional heat stroke treated with a hemoadsorber CytoSorb: lesson for the clinical nephrologist®
    Mikacic, Marijana
    Begovic, Tanja Ilic
    Jerkovic, Ivan
    Batinic, Marina Maras
    Kovacic, Vedran
    JOURNAL OF NEPHROLOGY, 2024, 37 (5) : 1379 - 1382
  • [3] Blood purification with a cytokine adsorber for the elimination of myoglobin in critically ill patients with severe rhabdomyolysis
    Christina Scharf
    Uwe Liebchen
    Michael Paal
    Michael Irlbeck
    Michael Zoller
    Ines Schroeder
    Critical Care, 25
  • [4] Blood purification with a cytokine adsorber for the elimination of myoglobin in critically ill patients with severe rhabdomyolysis
    Scharf, Christina
    Liebchen, Uwe
    Paal, Michael
    Irlbeck, Michael
    Zoller, Michael
    Schroeder, Ines
    CRITICAL CARE, 2021, 25 (01)
  • [5] Successful Reduction of Creatine Kinase and Myoglobin Levels in Severe Rhabdomyolysis Using Extracorporeal Blood Purification (CytoSorb®)
    Dilken, Olcay
    Ince, Can
    Van der Hoven, Ben
    Thijsse, Sjoerd
    Ormskerk, Patricia
    De Geus, Hilde R. H.
    BLOOD PURIFICATION, 2020, 49 (06) : 743 - 747
  • [6] The effect of cytosorb® application on kidney recovery in critically ill patients with severe rhabdomyolysis: a propensity score matching analysis
    Graefe, Caroline
    Liebchen, Uwe
    Greimel, Antonia
    Maciuga, Nils
    Bruegel, Mathias
    Irlbeck, Michael
    Weidhase, Lorenz
    Zoller, Michael
    Paal, Michael
    Scharf, Christina
    RENAL FAILURE, 2023, 45 (02)
  • [7] Effects of Hemoadsorption with CytoSorb during Severe Rhabdomyolysis
    Daum, Hannah C.
    Schmidt, Bernhard M. W.
    Napp, Lars Christian
    BLOOD PURIFICATION, 2021, 50 (02) : 268 - 269
  • [8] Rapid reduction of substantially increased myoglobin and creatine kinase levels using a hemoadsorption device (CytoSorb®)-A case report
    Moresco, Erich
    Rugg, Christopher
    Strohle, Mathias
    Thoma, Matthias
    CLINICAL CASE REPORTS, 2022, 10 (01):
  • [9] High Cut-Off Renal Replacement Therapy for Removal of Myoglobin in Severe Rhabdomyolysis and Acute Kidney Injury: A Case Series
    Heyne, Nils
    Guthoff, Martina
    Krieger, Julia
    Haap, Michael
    Haering, Hans-Ulrich
    NEPHRON CLINICAL PRACTICE, 2012, 121 (3-4): : C159 - C164
  • [10] Kinetic modelling of haemodialysis removal of myoglobin in rhabdomyolysis patients
    Keir, R.
    Evans, N. D.
    Hutchison, C. A.
    Vigano, M. R.
    Stella, A.
    Fabbrini, P.
    Storr, M.
    Chappell, M. J.
    COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2014, 114 (03) : E29 - E38